The FDA has cleared Micro Dose by EOS imaging, a low dose option now available on EOS equipment.
EOS imaging received U.S. FDA clearance for Micro Dose, an option now available on EOS equipment that lowers dose of pediatric spine follow-up imaging exams, the company announced.
Micro Dose is designed for pediatric patients with orthopedic conditions that require frequent imaging exams for continuous monitoring of disease progression and treatment, the company said. Initial results presented at RSNA 1014 showed that Micro Dose generates dosage levels equivalent to a week of naturally-occurring background radiation in pediatric patients receiving 2D and 3D follow-up examinations, the company announced.
Micro Dose is in full accordance with the As Low As Reasonably Achievable (ALARA) principle, Marie Meynadier, CEO of EOS imaging, said in a release.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.